Implementation notice: Waiting time modifications for candidates affected by race-inclusive eGFR calculations
Programs must complete the process and provide the necessary documentation to the OPTN by Jan. 3, 2024.
Programs must complete the process and provide the necessary documentation to the OPTN by Jan. 3, 2024.
This policy change is intended to more accurately reflect patient sensitization.
OPOs are now required to make a reasonable effort to perform renal procurement biopsies for deceased kidney donors meeting certain criteria.
Effective Sept. 6, OPOs will be required to perform renal procurement biopsies for deceased kidney donors meeting certain criteria.
Changes to HLA and unacceptable antigen options will go into effect Aug. 30, as well as changes to the equivalences used for HLA matching and screening of unacceptable antigens between candidates and donors.
Transplant hospitals are able to take immediate action to benefit a select population of Black candidates impacted by race-inclusive eGFR calculations.